Zhengye Biotechnology Holding (ZYBT) Long-Term Deferred Tax (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Long-Term Deferred Tax for 3 consecutive years, with $14663.2 the latest figure, recorded in Q4 2025.

• Quarterly Long-Term Deferred Tax fell 99.04% year-over-year to $14663.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14663.2 (down 99.04% YoY) and the FY2025 annual result came in at $15000.0, down 99.0% from the prior year.
• Long-Term Deferred Tax fell to $14663.2 in Q4 2025 per ZYBT's latest filing, from $2.3 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for ZYBT reached as high as $2.3 million in Q2 2025 and fell as low as $14663.2 in Q4 2025.
• A 3-year average of $1.4 million and a median of $1.6 million in 2023 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2024 — Long-Term Deferred Tax slipped 7.53% — and 2025, when it sank 99.04%.
• Year by year, Long-Term Deferred Tax stood at $1.7 million in 2023, then retreated by 7.53% to $1.5 million in 2024, then slumped by 99.04% to $14663.2 in 2025.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $14663.2, $2.3 million, and $1.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.